Posted inMarket
Tarsus Pharmaceuticals Stock Reaches Record High of 85.29 USD
Tarsus Pharmaceuticals stock achieves a new milestone, hitting an all-time high of 85.29 USD. Discover the latest market valuation details.
Posted inMarket
Amphastar Senior EVP Rong Zhou Executes Stock Sale Totaling 75,305 Dollars
Amphastar senior executive Rong Zhou recently sold company shares valued at 75,305 dollars, according to recent regulatory filings.
Posted inMarket
Vertex Pharmaceuticals Secures Top Spot on Citi Biotech Picks
Vertex Pharmaceuticals claims the top position on Citi's biotech stock picks following the successful completion of the Crinetics acquisition.
Posted inMarket
BetterLife Pharma Welcomes Charles Duncan to Board of Directors
BetterLife Pharma has appointed industry veteran Charles Duncan to its board of directors, strengthening its strategic leadership team.
Posted inBusiness Insights
Piramal Pharma Braces for Massive ₹1,750 Crore Block Deal as Shares Edge Higher
Piramal Pharma shares rise as investors brace for a massive 1750 crore block deal with a major six percent stake sale on the horizon.
Posted inBusiness Insights
Eli Lilly’s Next-Generation Weight-Loss Drug Clears Critical Heart Safety Hurdle
Pharmaceutical giant Eli Lilly & Co. announced this week that its experimental, next-generation weight-loss therapy demonstrated no overall increase in cardiovascular risk in a major clinical evaluation, successfully clearing a…
Posted inBusiness Insights
Cipla Reaffirms Full-Year Profit Guidance as $1 Billion US Revenue Target Paves Way for FY27 Growth Ramp-Up
Indian pharmaceutical major Cipla Limited announced it is maintaining its full-year EBITDA margin guidance of 18.5% to 20%, anchored by a projected U.S. sales run rate of $1 billion by…
Posted inBusiness Insights
Kedaara Capital Leads Bid for Controlling Stake in Olive PharmaScience
Private equity firm Kedaara Capital has emerged as the frontrunner to acquire a significant stake in Olive PharmaScience, a strategic move that industry analysts value at approximately ₹4,500 crore. The…
Posted inEmerging Market
Medicare’s Landmark Coverage Shift: What Seniors Need to Know About Obesity Drug Access
Medicare now covers obesity drugs for heart health; learn how this landmark policy shift impacts your access to life-changing medication.
